Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis - PubMed (original) (raw)
Review
. 1999 Mar 19;84(5):489-97.
doi: 10.1161/01.res.84.5.489.
Affiliations
- PMID: 10082470
- DOI: 10.1161/01.res.84.5.489
Review
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
A M Schmidt et al. Circ Res. 1999.
Abstract
Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules and engages diverse ligands relevant to distinct pathological processes. One class of RAGE ligands includes glycoxidation products, termed advanced glycation end products, which occur in diabetes, at sites of oxidant stress in tissues, and in renal failure and amyloidoses. RAGE also functions as a signal transduction receptor for amyloid beta peptide, known to accumulate in Alzheimer disease in both affected brain parenchyma and cerebral vasculature. Interaction of RAGE with these ligands enhances receptor expression and initiates a positive feedback loop whereby receptor occupancy triggers increased RAGE expression, thereby perpetuating another wave of cellular activation. Sustained expression of RAGE by critical target cells, including endothelium, smooth muscle cells, mononuclear phagocytes, and neurons, in proximity to these ligands, sets the stage for chronic cellular activation and tissue damage. In a model of accelerated atherosclerosis associated with diabetes in genetically manipulated mice, blockade of cell surface RAGE by infusion of a soluble, truncated form of the receptor completely suppressed enhanced formation of vascular lesions. Amelioration of atherosclerosis in these diabetic/atherosclerotic animals by soluble RAGE occurred in the absence of changes in plasma lipids or glycemia, emphasizing the contribution of a lipid- and glycemia-independent mechanism(s) to atherogenesis, which we postulate to be interaction of RAGE with its ligands. Future studies using mice in which RAGE expression has been genetically manipulated and with selective low molecular weight RAGE inhibitors will be required to definitively assign a critical role for RAGE activation in diabetic vasculopathy. However, sustained receptor expression in a microenvironment with a plethora of ligand makes possible prolonged receptor stimulation, suggesting that interaction of cellular RAGE with its ligands could be a factor contributing to a range of important chronic disorders.
Similar articles
- The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
Ramasamy R, Yan SF, Schmidt AM. Ramasamy R, et al. Trends Cardiovasc Med. 2005 Oct;15(7):237-43. doi: 10.1016/j.tcm.2005.08.003. Trends Cardiovasc Med. 2005. PMID: 16226677 Review. - Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM, Yan SD, Yan SF, Schmidt AM. Stern DM, et al. Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9. Ageing Res Rev. 2002. PMID: 12039445 Review. - The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM, Yan SD, Yan SF, Stern DM. Schmidt AM, et al. Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2. Biochim Biophys Acta. 2000. PMID: 11108954 Review. - Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM. Wendt T, et al. Curr Atheroscler Rep. 2002 May;4(3):228-37. doi: 10.1007/s11883-002-0024-4. Curr Atheroscler Rep. 2002. PMID: 11931721 Review. - The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O, Yan SD, Ogawa S, Kuwabara K, Matsumoto M, Stern D, Schmidt AM. Hori O, et al. Nephrol Dial Transplant. 1996;11 Suppl 5:13-6. doi: 10.1093/ndt/11.supp5.13. Nephrol Dial Transplant. 1996. PMID: 9044300 Review.
Cited by
- Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners.
Shibib L, Al-Qaisi M, Guess N, Miras AD, Greenwald SE, Pelling M, Ahmed A. Shibib L, et al. Diabetes Metab Syndr Obes. 2024 Aug 23;17:3111-3130. doi: 10.2147/DMSO.S458894. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39206417 Free PMC article. Review. - Acute Myocardial Infarction in a Seven-Year-Old Child With Type 1 Diabetes: A Rare Case Report.
Hajaj H, Elouali A, Ghanam A, Rkain M, Babakhouya A. Hajaj H, et al. Cureus. 2024 Jun 22;16(6):e62909. doi: 10.7759/cureus.62909. eCollection 2024 Jun. Cureus. 2024. PMID: 39040722 Free PMC article. - Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review.
Dănilă AI, Ghenciu LA, Stoicescu ER, Bolintineanu SL, Iacob R, Săndesc MA, Faur AC. Dănilă AI, et al. Biomedicines. 2024 Mar 27;12(4):747. doi: 10.3390/biomedicines12040747. Biomedicines. 2024. PMID: 38672103 Free PMC article. Review. - Cardiometabolic and immune response to exercise training in patients with metabolic syndrome: retrospective analysis of two randomized clinical trials.
Lechner K, Kia S, von Korn P, Dinges SM, Mueller S, Tjønna AE, Wisløff U, Van Craenenbroeck EM, Pieske B, Adams V, Pressler A, Landmesser U, Halle M, Kränkel N. Lechner K, et al. Front Cardiovasc Med. 2024 Apr 3;11:1329633. doi: 10.3389/fcvm.2024.1329633. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38638882 Free PMC article. - Discovery of Potential RAGE inhibitors using Receptor-Based Pharmacophore Modeling, High Throughput Virtual Screening and Docking Studies.
Singh H, Agrawal DK. Singh H, et al. J Biotechnol Biomed. 2023;6(4):501-513. doi: 10.26502/jbb.2642-91280112. Epub 2023 Oct 25. J Biotechnol Biomed. 2023. PMID: 38050632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical